title: Combining genetic variations in CYP2C9 and VKORC1 with clinical factors for warfarin dosing determination improved clinical effectiveness.
authors.affiliation: Division of Bioinformatics & Biostatistics, National Center for Toxicological Research, US FDA, 3900 NCTR Road, Jefferson, AR 72079, USA. huixiao.hong@fda.hhs.gov
authors.forename: Huixiao
authors.initials: H
authors.lastname: Hong
authors.forename: Ansar
authors.initials: A
authors.lastname: Jawaid
authors.forename: Jian
authors.initials: J
authors.lastname: Wang
authors.forename: Jennifer
authors.initials: J
authors.lastname: Catalano
authors.forename: Jayne C
authors.initials: JC
authors.lastname: Fox
authors.forename: Troy B
authors.initials: TB
authors.lastname: Hawkins